Literature DB >> 15758699

Early stage prostate cancer--do we have a problem with over-detection, overtreatment or both?

Peter R Carroll.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15758699     DOI： 10.1097/01.ju.0000156838.67623.10

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  27 in total

1.  Metastasis as a therapeutic target in prostate cancer: a conceptual framework.

Authors:  Konstantin Stoletov; David Bond; Katie Hebron; Srijan Raha; Andries Zijlstra; John D Lewis
Journal:  Am J Clin Exp Urol       Date:  2014-04

2.  Prognostic value of transformer 2β expression in prostate cancer.

Authors:  Yan Diao; Dong Wu; Zhijun Dai; Huafeng Kang; Ziming Wang; Xijing Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

3.  The changing face of prostate cancer: can gains in epigenetic knowledge translate into improvements in clinical care?

Authors:  James W F Catto
Journal:  J Mol Med (Berl)       Date:  2006-10-05       Impact factor: 4.599

4.  Technique development of 3D dynamic CS-EPSI for hyperpolarized 13 C pyruvate MR molecular imaging of human prostate cancer.

Authors:  Hsin-Yu Chen; Peder E Z Larson; Jeremy W Gordon; Robert A Bok; Marcus Ferrone; Mark van Criekinge; Lucas Carvajal; Peng Cao; John M Pauly; Adam B Kerr; Ilwoo Park; James B Slater; Sarah J Nelson; Pamela N Munster; Rahul Aggarwal; John Kurhanewicz; Daniel B Vigneron
Journal:  Magn Reson Med       Date:  2018-03-25       Impact factor: 4.668

5.  Association between percentage of tumor involvement and Gleason score upgrading in low-risk prostate cancer.

Authors:  Qiang Fu; Judd W Moul; Lionel L Bañez; Leon Sun; Vladimir Mouraviev; Dongha Xie; Thomas J Polascik
Journal:  Med Oncol       Date:  2012-06-12       Impact factor: 3.064

6.  Incremental value of magnetic resonance imaging in the advanced management of prostate cancer.

Authors:  Liang Wang
Journal:  World J Radiol       Date:  2009-12-31

7.  A new approach to understanding racial disparities in prostate cancer treatment.

Authors:  Carolyn J Presley; Ann C Raldow; Laura D Cramer; Pamela R Soulos; Jessica B Long; James B Yu; Danil V Makarov; Cary P Gross
Journal:  J Geriatr Oncol       Date:  2013-01       Impact factor: 3.599

8.  Five-year downstream outcomes following prostate-specific antigen screening in older men.

Authors:  Louise C Walter; Kathy Z Fung; Katharine A Kirby; Ying Shi; Roxanne Espaldon; Sarah O'Brien; Stephen J Freedland; Adam A Powell; Richard M Hoffman
Journal:  JAMA Intern Med       Date:  2013-05-27       Impact factor: 21.873

Review 9.  Advances in MR spectroscopy of the prostate.

Authors:  John Kurhanewicz; Daniel B Vigneron
Journal:  Magn Reson Imaging Clin N Am       Date:  2008-11       Impact factor: 2.266

10.  Focal treatment or observation of prostate cancer: pretreatment accuracy of transrectal ultrasound biopsy and T2-weighted MRI.

Authors:  Lucas Nogueira; Liang Wang; Samson W Fine; Rodrigo Pinochet; Jordan M Kurta; Darren Katz; Caroline J Savage; Angel M Cronin; Hedvig Hricak; Peter T Scardino; Oguz Akin; Jonathan A Coleman
Journal:  Urology       Date:  2009-07-30       Impact factor: 2.649
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.